---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-031778"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:28:35.992944+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics amends bylaws to reduce director removal threshold to majority vote and add exclusive forum provisions

## Summary
- Reduced director removal with cause threshold from 66 2/3% to a majority of voting holders.
- Added exclusive forum provision requiring internal corporate suits be brought in Delaware courts.
- Added federal forum selection clause for Securities Act claims unless company consents otherwise.

## SEC filing metadata
- accession: 0001140361-24-031778
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036124031778/0001140361-24-031778-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124031778/ef20031848_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-031778
- JSON: https://secwatch.observer/filing/0001140361-24-031778.json
- Plain text: https://secwatch.observer/filing/0001140361-24-031778.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.